APO Research

APO RESEARCH · REPORT

Iodinated X-Ray Contrast Media

Selected research

Market Structure

Global Iodinated X-Ray Contrast Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Iodinated X-Ray Contrast Media market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Iodinated X-Ray Contrast Media include Bayer, Bracco, Cadiasun Pharma GmbH, Daiichi Sankyo, Fuji Pharma, GE Healthcare, Grupo Juste, Guerbet and Imax, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iodinated X-Ray Contrast Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iodinated X-Ray Contrast Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iodinated X-Ray Contrast Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iodinated X-Ray Contrast Media market size, projected growth trends, production technologies, key applications, and end-use industries.

Iodinated X-Ray Contrast Media Segment by Company

Bayer

Bracco

Cadiasun Pharma GmbH

Daiichi Sankyo

Fuji Pharma

GE Healthcare

Grupo Juste

Guerbet

Imax

Liebel-Flarsheim Company LLC

Neptunus Bio-pharmaceutical

Takeda

BeiLu Pharma

Brilliant Pharmaceutical

Hengrui Pharmaceuticals

Consun Pharmaceutical

Shenghuaxi Pharmaceutical

YRPG

CTTQ

Iodinated X-Ray Contrast Media Segment by Type

Iodixanol

Iohexol

Ioversol

Iobitrol

Others

Iodinated X-Ray Contrast Media Segment by Application

Hospital

Clinic

Others

Iodinated X-Ray Contrast Media Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iodinated X-Ray Contrast Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iodinated X-Ray Contrast Media and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iodinated X-Ray Contrast Media.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iodinated X-Ray Contrast Media market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Iodinated X-Ray Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Iodinated X-Ray Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Iodinated X-Ray Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Iodinated X-Ray Contrast Media Industry Trends Table 2. Iodinated X-Ray Contrast Media Industry Drivers Table 3. Iodinated X-Ray Contrast Media Industry Opportunities and Challenges Table 4. Iodinated X-Ray Contrast Media Industry Restraints Table 5. Global Iodinated X-Ray Contrast Media Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Iodinated X-Ray Contrast Media Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Iodinated X-Ray Contrast Media Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Iodinated X-Ray Contrast Media Sales Market Share by Manufacturers Table 9. Global Iodinated X-Ray Contrast Media Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Iodinated X-Ray Contrast Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Iodinated X-Ray Contrast Media Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Iodinated X-Ray Contrast Media Manufacturers, Product Type & Application Table 13. Global Iodinated X-Ray Contrast Media Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Iodinated X-Ray Contrast Media by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Iodixanol Table 17. Major Manufacturers of Iohexol Table 18. Major Manufacturers of Ioversol Table 19. Major Manufacturers of Iobitrol Table 20. Major Manufacturers of Others Table 21. Global Iodinated X-Ray Contrast Media Sales by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Iodinated X-Ray Contrast Media Sales by Type (2021-2026) & (Units) Table 23. Global Iodinated X-Ray Contrast Media Sales by Type (2027-2032) & (Units) Table 24. Global Iodinated X-Ray Contrast Media Sales Market Share by Type (2021-2026) Table 25. Global Iodinated X-Ray Contrast Media Sales Market Share by Type (2027-2032) Table 26. Global Iodinated X-Ray Contrast Media Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 27. Global Iodinated X-Ray Contrast Media Revenue by Type (2021-2026) & (Units) Table 28. Global Iodinated X-Ray Contrast Media Revenue by Type (2027-2032) & (Units) Table 29. Global Iodinated X-Ray Contrast Media Revenue Market Share by Type (2021-2026) Table 30. Global Iodinated X-Ray Contrast Media Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Iodinated X-Ray Contrast Media Sales by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Iodinated X-Ray Contrast Media Sales by Application (2021-2026) & (Units) Table 36. Global Iodinated X-Ray Contrast Media Sales by Application (2027-2032) & (Units) Table 37. Global Iodinated X-Ray Contrast Media Sales Market Share by Application (2021-2026) Table 38. Global Iodinated X-Ray Contrast Media Sales Market Share by Application (2027-2032) Table 39. Global Iodinated X-Ray Contrast Media Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 40. Global Iodinated X-Ray Contrast Media Revenue by Application (2021-2026) & (Units) Table 41. Global Iodinated X-Ray Contrast Media Revenue by Application (2027-2032) & (Units) Table 42. Global Iodinated X-Ray Contrast Media Revenue Market Share by Application (2021-2026) Table 43. Global Iodinated X-Ray Contrast Media Revenue Market Share by Application (2027-2032) Table 44. Global Iodinated X-Ray Contrast Media Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Iodinated X-Ray Contrast Media Sales by Region (2021-2026) & (Units) Table 46. Global Iodinated X-Ray Contrast Media Sales Market Share by Region (2021-2026) Table 47. Global Iodinated X-Ray Contrast Media Sales Forecasted by Region (2027-2032) & (Units) Table 48. Global Iodinated X-Ray Contrast Media Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. North America Iodinated X-Ray Contrast Media Sales by Country (2021-2026) & (Units) Table 51. North America Iodinated X-Ray Contrast Media Sales by Country (2027-2032) & (Units) Table 52. Europe Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Europe Iodinated X-Ray Contrast Media Sales by Country (2021-2026) & (Units) Table 54. Europe Iodinated X-Ray Contrast Media Sales by Country (2027-2032) & (Units) Table 55. Asia Pacific Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Asia Pacific Iodinated X-Ray Contrast Media Sales by Country (2021-2026) & (Units) Table 57. Asia Pacific Iodinated X-Ray Contrast Media Sales by Country (2027-2032) & (Units) Table 58. South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 59. South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales by Country (2021-2026) & (Units) Table 60. South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales by Country (2027-2032) & (Units) Table 61. Global Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Iodinated X-Ray Contrast Media Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Iodinated X-Ray Contrast Media Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Iodinated X-Ray Contrast Media Revenue Market Share by Region (2021-2026) Table 65. Global Iodinated X-Ray Contrast Media Revenue Market Share by Region (2027-2032) Table 66. Bayer Company Information Table 67. Bayer Business Overview Table 68. Bayer Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bayer Iodinated X-Ray Contrast Media Product Portfolio Table 70. Bayer Recent Development Table 71. Bracco Company Information Table 72. Bracco Business Overview Table 73. Bracco Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bracco Iodinated X-Ray Contrast Media Product Portfolio Table 75. Bracco Recent Development Table 76. Cadiasun Pharma GmbH Company Information Table 77. Cadiasun Pharma GmbH Business Overview Table 78. Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Product Portfolio Table 80. Cadiasun Pharma GmbH Recent Development Table 81. Daiichi Sankyo Company Information Table 82. Daiichi Sankyo Business Overview Table 83. Daiichi Sankyo Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Daiichi Sankyo Iodinated X-Ray Contrast Media Product Portfolio Table 85. Daiichi Sankyo Recent Development Table 86. Fuji Pharma Company Information Table 87. Fuji Pharma Business Overview Table 88. Fuji Pharma Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Fuji Pharma Iodinated X-Ray Contrast Media Product Portfolio Table 90. Fuji Pharma Recent Development Table 91. GE Healthcare Company Information Table 92. GE Healthcare Business Overview Table 93. GE Healthcare Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. GE Healthcare Iodinated X-Ray Contrast Media Product Portfolio Table 95. GE Healthcare Recent Development Table 96. Grupo Juste Company Information Table 97. Grupo Juste Business Overview Table 98. Grupo Juste Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Grupo Juste Iodinated X-Ray Contrast Media Product Portfolio Table 100. Grupo Juste Recent Development Table 101. Guerbet Company Information Table 102. Guerbet Business Overview Table 103. Guerbet Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Guerbet Iodinated X-Ray Contrast Media Product Portfolio Table 105. Guerbet Recent Development Table 106. Imax Company Information Table 107. Imax Business Overview Table 108. Imax Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Imax Iodinated X-Ray Contrast Media Product Portfolio Table 110. Imax Recent Development Table 111. Liebel-Flarsheim Company LLC Company Information Table 112. Liebel-Flarsheim Company LLC Business Overview Table 113. Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Product Portfolio Table 115. Liebel-Flarsheim Company LLC Recent Development Table 116. Neptunus Bio-pharmaceutical Company Information Table 117. Neptunus Bio-pharmaceutical Business Overview Table 118. Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 120. Neptunus Bio-pharmaceutical Recent Development Table 121. Takeda Company Information Table 122. Takeda Business Overview Table 123. Takeda Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Takeda Iodinated X-Ray Contrast Media Product Portfolio Table 125. Takeda Recent Development Table 126. BeiLu Pharma Company Information Table 127. BeiLu Pharma Business Overview Table 128. BeiLu Pharma Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. BeiLu Pharma Iodinated X-Ray Contrast Media Product Portfolio Table 130. BeiLu Pharma Recent Development Table 131. Brilliant Pharmaceutical Company Information Table 132. Brilliant Pharmaceutical Business Overview Table 133. Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 135. Brilliant Pharmaceutical Recent Development Table 136. Hengrui Pharmaceuticals Company Information Table 137. Hengrui Pharmaceuticals Business Overview Table 138. Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Product Portfolio Table 140. Hengrui Pharmaceuticals Recent Development Table 141. Consun Pharmaceutical Company Information Table 142. Consun Pharmaceutical Business Overview Table 143. Consun Pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Consun Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 145. Consun Pharmaceutical Recent Development Table 146. Shenghuaxi Pharmaceutical Company Information Table 147. Shenghuaxi Pharmaceutical Business Overview Table 148. Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 150. Shenghuaxi Pharmaceutical Recent Development Table 151. YRPG Company Information Table 152. YRPG Business Overview Table 153. YRPG Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. YRPG Iodinated X-Ray Contrast Media Product Portfolio Table 155. YRPG Recent Development Table 156. CTTQ Company Information Table 157. CTTQ Business Overview Table 158. CTTQ Iodinated X-Ray Contrast Media Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. CTTQ Iodinated X-Ray Contrast Media Product Portfolio Table 160. CTTQ Recent Development Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Iodinated X-Ray Contrast Media Distributors List Table 164. Iodinated X-Ray Contrast Media Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Iodinated X-Ray Contrast Media Product Image Figure 2. Global Iodinated X-Ray Contrast Media Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iodinated X-Ray Contrast Media Market Size (2021-2032) & (US$ Million) Figure 4. Global Iodinated X-Ray Contrast Media Sales (2021-2032) & (Units) Figure 5. Global Iodinated X-Ray Contrast Media Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Iodinated X-Ray Contrast Media Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Iodixanol Image Figure 9. Iohexol Image Figure 10. Ioversol Image Figure 11. Iobitrol Image Figure 12. Others Image Figure 13. Global Iodinated X-Ray Contrast Media Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Iodinated X-Ray Contrast Media Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Iodinated X-Ray Contrast Media Sales Market Share by Type (2021-2032) Figure 16. Global Iodinated X-Ray Contrast Media Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 17. Global Iodinated X-Ray Contrast Media Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Iodinated X-Ray Contrast Media Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Iodinated X-Ray Contrast Media Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Iodinated X-Ray Contrast Media Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Iodinated X-Ray Contrast Media Sales Market Share by Application (2021-2032) Figure 25. Global Iodinated X-Ray Contrast Media Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 26. Global Iodinated X-Ray Contrast Media Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Iodinated X-Ray Contrast Media Revenue Market Share by Application (2021-2032) Figure 28. North America Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 29. North America Iodinated X-Ray Contrast Media Sales Market Share by Country (2021-2032) Figure 30. U.S. Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 31. Canada Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 32. Mexico Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 33. Europe Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 34. Europe Iodinated X-Ray Contrast Media Sales Market Share by Country (2021-2032) Figure 35. Germany Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 36. France Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 37. U.K. Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 38. Italy Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 39. Netherlands Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 40. Asia Pacific Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 41. Asia Pacific Iodinated X-Ray Contrast Media Sales Market Share by Country (2021-2032) Figure 42. China Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 43. Japan Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 44. South Korea Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 45. Southeast Asia Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 46. India Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 47. Australia Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 48. South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 49. South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales Market Share by Country (2021-2032) Figure 50. Brazil Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 51. South Africa Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 52. Saudi Arabia Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 53. Turkey Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 54. Argentina Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 55. UAE Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 56. Egypt Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 57. Chile Iodinated X-Ray Contrast Media Sales and Growth Rate (2021-2032) & (Units) Figure 58. Global Iodinated X-Ray Contrast Media Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Iodinated X-Ray Contrast Media Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Iodinated X-Ray Contrast Media Revenue (2021-2032) & (US$ Million) Figure 61. North America Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Iodinated X-Ray Contrast Media Revenue (2021-2032) & (US$ Million) Figure 63. Europe Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Iodinated X-Ray Contrast Media Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Iodinated X-Ray Contrast Media Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Iodinated X-Ray Contrast Media Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Iodinated X-Ray Contrast Media Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Iodixanol
  • Iohexol
  • Ioversol
  • Iobitrol
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Bayer
  • Bracco
  • Cadiasun Pharma GmbH
  • Daiichi Sankyo
  • Fuji Pharma
  • GE Healthcare
  • Grupo Juste
  • Guerbet
  • Imax
  • Liebel-Flarsheim Company LLC
  • Neptunus Bio-pharmaceutical
  • Takeda
  • BeiLu Pharma
  • Brilliant Pharmaceutical
  • Hengrui Pharmaceuticals
  • Consun Pharmaceutical
  • Shenghuaxi Pharmaceutical
  • YRPG
  • CTTQ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Iodinated X-Ray Contrast Media Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Iodinated X-Ray Contrast Media Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Iodinated X-Ray Contrast Media Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Iodinated X-Ray Contrast Media Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Iodinated X-Ray Contrast Media Market Dynamics
  1. 2.1 Iodinated X-Ray Contrast Media Industry Trends
  2. 2.2 Iodinated X-Ray Contrast Media Industry Drivers
  3. 2.3 Iodinated X-Ray Contrast Media Industry Opportunities and Challenges
  4. 2.4 Iodinated X-Ray Contrast Media Industry Restraints
3 Iodinated X-Ray Contrast Media Market by Manufacturers
  1. 3.1 Global Iodinated X-Ray Contrast Media Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Iodinated X-Ray Contrast Media Sales by Manufacturers (2021-2026)
  3. 3.3 Global Iodinated X-Ray Contrast Media Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Iodinated X-Ray Contrast Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Iodinated X-Ray Contrast Media Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Iodinated X-Ray Contrast Media Manufacturers, Product Type & Application
  7. 3.7 Global Iodinated X-Ray Contrast Media Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Iodinated X-Ray Contrast Media Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Iodinated X-Ray Contrast Media Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Iodinated X-Ray Contrast Media Tier 1, Tier 2, and Tier 3
4 Iodinated X-Ray Contrast Media Market by Type
  1. 4.1 Iodinated X-Ray Contrast Media Type Introduction
  2. 4.1.1 Iodixanol
  3. 4.1.2 Iohexol
  4. 4.1.3 Ioversol
  5. 4.1.4 Iobitrol
  6. 4.1.5 Others
  7. 4.2 Global Iodinated X-Ray Contrast Media Sales by Type
  8. 4.2.1 Global Iodinated X-Ray Contrast Media Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Iodinated X-Ray Contrast Media Sales by Type (2021-2032)
  10. 4.2.3 Global Iodinated X-Ray Contrast Media Sales Market Share by Type (2021-2032)
  11. 4.3 Global Iodinated X-Ray Contrast Media Revenue by Type
  12. 4.3.1 Global Iodinated X-Ray Contrast Media Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Iodinated X-Ray Contrast Media Revenue by Type (2021-2032)
  14. 4.3.3 Global Iodinated X-Ray Contrast Media Revenue Market Share by Type (2021-2032)
5 Iodinated X-Ray Contrast Media Market by Application
  1. 5.1 Iodinated X-Ray Contrast Media Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Iodinated X-Ray Contrast Media Sales by Application
  6. 5.2.1 Global Iodinated X-Ray Contrast Media Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Iodinated X-Ray Contrast Media Sales by Application (2021-2032)
  8. 5.2.3 Global Iodinated X-Ray Contrast Media Sales Market Share by Application (2021-2032)
  9. 5.3 Global Iodinated X-Ray Contrast Media Revenue by Application
  10. 5.3.1 Global Iodinated X-Ray Contrast Media Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Iodinated X-Ray Contrast Media Revenue by Application (2021-2032)
  12. 5.3.3 Global Iodinated X-Ray Contrast Media Revenue Market Share by Application (2021-2032)
6 Global Iodinated X-Ray Contrast Media Sales by Region
  1. 6.1 Global Iodinated X-Ray Contrast Media Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iodinated X-Ray Contrast Media Sales by Region (2021-2032)
  3. 6.2.1 Global Iodinated X-Ray Contrast Media Sales by Region (2021-2026)
  4. 6.2.2 Global Iodinated X-Ray Contrast Media Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Iodinated X-Ray Contrast Media Revenue by Region
  1. 7.1 Global Iodinated X-Ray Contrast Media Revenue by Region
  2. 7.1.1 Global Iodinated X-Ray Contrast Media Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Iodinated X-Ray Contrast Media Revenue by Region (2021-2026)
  4. 7.1.3 Global Iodinated X-Ray Contrast Media Revenue by Region (2027-2032)
  5. 7.1.4 Global Iodinated X-Ray Contrast Media Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Iodinated X-Ray Contrast Media Revenue (2021-2032)
  8. 7.2.2 North America Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Iodinated X-Ray Contrast Media Revenue (2021-2032)
  11. 7.3.2 Europe Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Iodinated X-Ray Contrast Media Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Iodinated X-Ray Contrast Media Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Iodinated X-Ray Contrast Media Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Bracco
  8. 8.2.1 Bracco Company Information
  9. 8.2.2 Bracco Business Overview
  10. 8.2.3 Bracco Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bracco Iodinated X-Ray Contrast Media Product Portfolio
  12. 8.2.5 Bracco Recent Developments
  13. 8.3 Cadiasun Pharma GmbH
  14. 8.3.1 Cadiasun Pharma GmbH Company Information
  15. 8.3.2 Cadiasun Pharma GmbH Business Overview
  16. 8.3.3 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Product Portfolio
  18. 8.3.5 Cadiasun Pharma GmbH Recent Developments
  19. 8.4 Daiichi Sankyo
  20. 8.4.1 Daiichi Sankyo Company Information
  21. 8.4.2 Daiichi Sankyo Business Overview
  22. 8.4.3 Daiichi Sankyo Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Daiichi Sankyo Iodinated X-Ray Contrast Media Product Portfolio
  24. 8.4.5 Daiichi Sankyo Recent Developments
  25. 8.5 Fuji Pharma
  26. 8.5.1 Fuji Pharma Company Information
  27. 8.5.2 Fuji Pharma Business Overview
  28. 8.5.3 Fuji Pharma Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fuji Pharma Iodinated X-Ray Contrast Media Product Portfolio
  30. 8.5.5 Fuji Pharma Recent Developments
  31. 8.6 GE Healthcare
  32. 8.6.1 GE Healthcare Company Information
  33. 8.6.2 GE Healthcare Business Overview
  34. 8.6.3 GE Healthcare Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GE Healthcare Iodinated X-Ray Contrast Media Product Portfolio
  36. 8.6.5 GE Healthcare Recent Developments
  37. 8.7 Grupo Juste
  38. 8.7.1 Grupo Juste Company Information
  39. 8.7.2 Grupo Juste Business Overview
  40. 8.7.3 Grupo Juste Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Grupo Juste Iodinated X-Ray Contrast Media Product Portfolio
  42. 8.7.5 Grupo Juste Recent Developments
  43. 8.8 Guerbet
  44. 8.8.1 Guerbet Company Information
  45. 8.8.2 Guerbet Business Overview
  46. 8.8.3 Guerbet Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guerbet Iodinated X-Ray Contrast Media Product Portfolio
  48. 8.8.5 Guerbet Recent Developments
  49. 8.9 Imax
  50. 8.9.1 Imax Company Information
  51. 8.9.2 Imax Business Overview
  52. 8.9.3 Imax Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Imax Iodinated X-Ray Contrast Media Product Portfolio
  54. 8.9.5 Imax Recent Developments
  55. 8.10 Liebel-Flarsheim Company LLC
  56. 8.10.1 Liebel-Flarsheim Company LLC Company Information
  57. 8.10.2 Liebel-Flarsheim Company LLC Business Overview
  58. 8.10.3 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Product Portfolio
  60. 8.10.5 Liebel-Flarsheim Company LLC Recent Developments
  61. 8.11 Neptunus Bio-pharmaceutical
  62. 8.11.1 Neptunus Bio-pharmaceutical Company Information
  63. 8.11.2 Neptunus Bio-pharmaceutical Business Overview
  64. 8.11.3 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  66. 8.11.5 Neptunus Bio-pharmaceutical Recent Developments
  67. 8.12 Takeda
  68. 8.12.1 Takeda Company Information
  69. 8.12.2 Takeda Business Overview
  70. 8.12.3 Takeda Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Takeda Iodinated X-Ray Contrast Media Product Portfolio
  72. 8.12.5 Takeda Recent Developments
  73. 8.13 BeiLu Pharma
  74. 8.13.1 BeiLu Pharma Company Information
  75. 8.13.2 BeiLu Pharma Business Overview
  76. 8.13.3 BeiLu Pharma Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BeiLu Pharma Iodinated X-Ray Contrast Media Product Portfolio
  78. 8.13.5 BeiLu Pharma Recent Developments
  79. 8.14 Brilliant Pharmaceutical
  80. 8.14.1 Brilliant Pharmaceutical Company Information
  81. 8.14.2 Brilliant Pharmaceutical Business Overview
  82. 8.14.3 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  84. 8.14.5 Brilliant Pharmaceutical Recent Developments
  85. 8.15 Hengrui Pharmaceuticals
  86. 8.15.1 Hengrui Pharmaceuticals Company Information
  87. 8.15.2 Hengrui Pharmaceuticals Business Overview
  88. 8.15.3 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Product Portfolio
  90. 8.15.5 Hengrui Pharmaceuticals Recent Developments
  91. 8.16 Consun Pharmaceutical
  92. 8.16.1 Consun Pharmaceutical Company Information
  93. 8.16.2 Consun Pharmaceutical Business Overview
  94. 8.16.3 Consun Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Consun Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  96. 8.16.5 Consun Pharmaceutical Recent Developments
  97. 8.17 Shenghuaxi Pharmaceutical
  98. 8.17.1 Shenghuaxi Pharmaceutical Company Information
  99. 8.17.2 Shenghuaxi Pharmaceutical Business Overview
  100. 8.17.3 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  102. 8.17.5 Shenghuaxi Pharmaceutical Recent Developments
  103. 8.18 YRPG
  104. 8.18.1 YRPG Company Information
  105. 8.18.2 YRPG Business Overview
  106. 8.18.3 YRPG Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 YRPG Iodinated X-Ray Contrast Media Product Portfolio
  108. 8.18.5 YRPG Recent Developments
  109. 8.19 CTTQ
  110. 8.19.1 CTTQ Company Information
  111. 8.19.2 CTTQ Business Overview
  112. 8.19.3 CTTQ Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 CTTQ Iodinated X-Ray Contrast Media Product Portfolio
  114. 8.19.5 CTTQ Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iodinated X-Ray Contrast Media Value Chain Analysis
  2. 9.1.1 Iodinated X-Ray Contrast Media Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iodinated X-Ray Contrast Media Production Mode & Process
  6. 9.2 Iodinated X-Ray Contrast Media Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iodinated X-Ray Contrast Media Distributors
  9. 9.2.3 Iodinated X-Ray Contrast Media Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research